ZD1839对免疫效应细胞裂解人肺腺癌A549细胞作用的影响
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
2005年第7期493-495,共3页
Chinese Journal of Tuberculosis and Respiratory Diseases
参考文献6
-
1Ciardiello F, Caputo R, Bianco R ,et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res,2001,7:1459-1465.
-
2Janmaat ML, Kruyt FA, Rodriguez JA, et al. Response to epidermal growth factor receptor inhibitors in non-small lung cancer cells:limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular singal-regulated kinase or Akt kinase pathways. Clin Cancer Res, 2003,9:2316-2326.
-
3Sirotnak FM, Zakowski MF, Miller VA ,et al. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res,2000,6:4885-4892.
-
4Ferry D, Hammond L, Ranson M, et al. Intermittent oral ZD1839 (Iressa), a novel epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), shows evidence of good tolerability and activity. Final results from a phase 1 study. Proc Am Soc Clin Oncol, 2000,19:3a.
-
5Cohen MH, Williams GA, Sridhara R,et al. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist, 2003,8:303-306.
-
6Naruse I, Ohmori T, Ao Y, et al. Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) IRESSA (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo. Int J Cancer, 2002,98:310-315.
-
1崔建东,胡义德.姜黄素与顺铂联合对人肺腺癌A549细胞增殖抑制作用的体外研究[J].四川医学,2006,27(1):1-3. 被引量：7
-
2Nakamura H,Takamori S,Fujii T.ZD1839和曲妥珠单抗联合治疗对NSCLC细胞生长的协同抑制作用[J].中国处方药,2006(1):51-51.
-
3伍彬,杨宗发.紫杉类药物药理及临床研究进展[J].中国药业,2004,13(6):77-78. 被引量：10
-
4王玉涛,杨丽萍.草酸铂联合替吉奥治疗晚期胃癌的疗效观察[J].实用医技杂志,2011,18(11):1184-1185.
-
5刘姝.紫杉类药物对晚期乳腺癌患者的临床疗效评价[J].抗感染药学,2016,13(2):470-471. 被引量：1
-
6袁立,郝金恒,张勇,王玉亚,王晖,陈皎月,宫平.4-(3-氯-4-氟苯胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的合成[J].中国药物化学杂志,2005,15(1):39-41. 被引量：8
-
7张艳华,宁华,姜洋.表皮生长因子受体酪氨酸激酶抑制剂吉非替尼[J].中国新药杂志,2004,13(10):947-950. 被引量：13
-
8孙利,李晓莉.非小细胞肺癌的靶向治疗进展[J].齐齐哈尔医学院学报,2009,30(15):1890-1892. 被引量：1
-
9许惠溢,奚燕,钟以胜,林碧英.多西紫杉醇联合斑蝥酸钠对人肺腺癌细胞增殖的抑制作用[J].中国药师,2011,14(6):786-788. 被引量：1
-
10戴宏宇,李苏宜,马国栋,万明月,徐玲,夏春伟,权琳,王毅,陈文萍.7种β-微管蛋白同型在非小细胞肺癌中的表达及其和紫杉类药物敏感性的研究[J].临床肺科杂志,2015,20(3):394-398. 被引量：3
